BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 2649347)

  • 1. [Angiotensin-converting enzyme inhibitors and ischemic heart disease].
    Ertl G; Kochsiek K
    Dtsch Med Wochenschr; 1989 Apr; 114(14):556-60. PubMed ID: 2649347
    [No Abstract]   [Full Text] [Related]  

  • 2. [Circulatory insufficiency, ischemic disease, arrhythmia and the renin-angiotensin-aldosterone system and angiotensin converting enzyme inhibitors].
    Gebalska J
    Kardiol Pol; 1992 May; 36(5):301-5. PubMed ID: 1625412
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of converting enzyme inhibitors on coronary flow and myocardial ischemia.
    van Gilst WH; Tio RA; van Wijngaarden J; de Graeff PA; Wesseling H
    J Cardiovasc Pharmacol; 1992; 19 Suppl 5():S134-9. PubMed ID: 1381790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Angiotensin converting enzyme inhibitors in ischemic heart disease].
    Takác M; Koval S; Takác V; Takác P
    Vnitr Lek; 1996 Apr; 42(4):290-6. PubMed ID: 8693718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The renin-angiotensin system as a target for therapeutic intervention.
    Swales JD
    J Cardiovasc Pharmacol; 1994; 24 Suppl 2():S1-5. PubMed ID: 7898088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cardiovascular pharmacology (IX). Angiotensin-converting enzyme inhibitors in hypertension and heart failure].
    de Teresa E; Espinosa JS; Gómez Doblas JJ
    Rev Esp Cardiol; 1995 Feb; 48(2):128-41. PubMed ID: 7886264
    [No Abstract]   [Full Text] [Related]  

  • 7. Angiotensin converting enzyme inhibitors and ischaemic heart disease.
    Ertl G
    Eur Heart J; 1988 Jul; 9(7):716-27. PubMed ID: 3049090
    [No Abstract]   [Full Text] [Related]  

  • 8. [Angiotensin-converting enzyme inhibitors in the treatment of heart failure: toward a change in the natural history of the disease].
    Martín Luengo C; Arribas Jiménez A; Nieto Ballestero F; Diego Domínguez M; Cascón Bueno M; Pabón Osuna P; Sala Sánchez-Castillo A
    Rev Esp Cardiol; 1993 Mar; 46(3):131-45. PubMed ID: 8488316
    [No Abstract]   [Full Text] [Related]  

  • 9. [The coronary circulation, renin-angiotensin system and ACE inhibition].
    Campa PP
    Cardiologia; 1995 Sep; 40(9):635-41. PubMed ID: 8542615
    [No Abstract]   [Full Text] [Related]  

  • 10. Angiotensin-converting enzyme inhibitors, inhibition of brain and peripheral angiotensin-converting enzymes, and left ventricular dysfunction in rats after myocardial infarction.
    Ahmad M; White R; Tan J; Huang BS; Leenen FH
    J Cardiovasc Pharmacol; 2008 Jun; 51(6):565-72. PubMed ID: 18496146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-ischemic properties of ACE-inhibitors.
    Deedwania PC
    Cardiologia; 1996 Mar; 41(3):209-15. PubMed ID: 8697478
    [No Abstract]   [Full Text] [Related]  

  • 12. Left ventricular remodeling after myocardial infarction: does the cardiac renin-angiotensin system play a role?
    Lindpaintner K; Niedermaier N; Drexler H; Ganten D
    J Cardiovasc Pharmacol; 1992; 20 Suppl 1():S41-7. PubMed ID: 1380618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurohormonal activation and the response to converting enzyme inhibitors in congestive heart failure.
    Kubo SH
    Circulation; 1990 Feb; 81(2 Suppl):III107-14. PubMed ID: 2137052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The significance of converting enzyme inhibitor angiotensin I to angiotensin II in treatment of patients with coronary disease].
    Halawa B
    Pol Merkur Lekarski; 1998 Jan; 4(19):32-4. PubMed ID: 9553407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined blockade of the renin-angiotensin system with angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor antagonists.
    Azizi M; Ménard J
    Circulation; 2004 Jun; 109(21):2492-9. PubMed ID: 15173039
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effect of angiotensin converting enzyme inhibitor lisinopril on sympathetic heart rate response during exercise in the early phase of acute myocardial infarction].
    Akashi Y; Tanabe K; Osada N; Samejima H; Seki A; Yokoyama Y; Nakayama M; Suzuki N; Oomiya K; Itoh H; Miyake F; Murayama M
    J Cardiol; 2000 Oct; 36(4):221-9. PubMed ID: 11079227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Future directions in cardiovascular pharmacology: examples from the Renin-Angiotensin system.
    Diz DI
    Mol Interv; 2008 Oct; 8(5):222-5. PubMed ID: 19015385
    [No Abstract]   [Full Text] [Related]  

  • 18. Endothelial dysfunction: the role and impact of the renin-angiotensin system.
    Lüscher TF
    Heart; 2000 Sep; 84 Suppl 1(Suppl 1):i20-2:discussion i50. PubMed ID: 10956315
    [No Abstract]   [Full Text] [Related]  

  • 19. Which inhibitor of the renin-angiotensin system should be used in chronic heart failure and acute myocardial infarction?
    McMurray JJ; Pfeffer MA; Swedberg K; Dzau VJ
    Circulation; 2004 Nov; 110(20):3281-8. PubMed ID: 15545527
    [No Abstract]   [Full Text] [Related]  

  • 20. [Anti-ischemic and infarction-reducing effects of angiotensin-converting enzyme inhibitors].
    Landmark K; Aursnes I
    Tidsskr Nor Laegeforen; 2001 Jun; 121(16):1923-6. PubMed ID: 11488184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.